Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-12

Clinical Trial Update: Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial comparing voriconazole to oral steroids for Allergic Bronchopulmonary Aspergillosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral steroids (systemic corticosteroids)
  • VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Allergic Bronchopulmonary Aspergillosis | Phase 2, Phase 3 | Status: COMPLETED